Concord Biotech, Corona Remedies, and SMS Pharmaceuticals Report Higher Q1 2026 Profits
Concord Biotech, Corona Remedies, and SMS Pharmaceuticals reported increased consolidated net profits for the quarter ended June 2026 compared to the same period in 2025. Concord Biotech's net profit rose 32.84% to Rs 58.53 crore on sales of Rs 257.49 crore. Corona Remedies saw a 30.11% net profit increase to Rs 60.11 crore with sales of Rs 422.43 crore. SMS Pharmaceuticals' net profit grew 2.05% to Rs 20.91 crore on sales of Rs 206.96 crore. All companies showed sales growth and improved profitability margins.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (64/100). Lens Score 36/100.
Outlets measured: businessstandard, businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–68/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 1 Aug, 03:43 am. Other outlets followed.